Recruitment And Diversity

1. Imunon Talks Passionate PIs, Endpoint Selection In Frontline Ovarian Cancer Trials 7/9/2025

   IMUNON CEO Stacy Lindborg, Ph.D. details the company’s successes in site selection, as well as trial design and execution, in Phase 2 and 3 trials for IMNN-001, a frontline treatment for ovarian cancer.

2. Dear Pharma, The Creator Economy Is NOT Only For Beauty 7/7/2025

   Empactful Ventures CEO Denise N. Bronner has a message for pharma when it comes to influencer marketing: Adapt or become invisible. Here, she details the hazards of overlooking this powerful media channel.

3. Accurate Diagnosis And Enrollment Criteria Improve Intracerebral Hemorrhage Research 7/2/2025

   CEO Marc Deschamps shares how ischemic stroke treatment has overshadowed that of intracerebral hemorrhage, negatively impacting recruitment for ICH clinical trials. To turn the tide, he advocates for accurate diagnoses, more specialized care, and less restrictive enrollment criteria.

4. Hey, What's The Big Idea? Patient Enrollment Utterly Reimagined, That's What 7/1/2025

   What do air traffic control, nuclear power plants, and aircraft carriers have in common? Patient recruitment expert Tatty Scott argues clinical researchers should look at these industries to inspire more precise trial execution.

5. BioMarin Generates Patient Experience Data With Early And Often Engagement 6/18/2025

   BioMarin Pharmaceutical's Ebony Dashiell-Aje, Ph.D., discusses how early and often patient engagement facilitates rich patient experience data generation.

6. J&J Survey Of Oncologists Reveals Challenges With Awareness & Access 6/12/2025

   J&J President, U.S. Solid Tumor Biljana Naumovic discusses the company's Oncology Care Index, which revealed issues with oncology provider awareness of and access to clinical trials.

7. Improving Recruitment Needs More Than Transactional Fixes To Earn Patient Trust 6/11/2025

   Driving patient recruitment and retention in clinical trials isn't always about scheduling, transportation, or even reimbursement. Often, and especially for marginalized communities, it begins with trust.

8. U.S. Tariffs And Their Tenuous Impact On Clinical Trials 6/10/2025

   RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

9. When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover 6/6/2025

   Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.

10. Regeneron Trials Balance Quest For "Scientific Truth" With Patient Impact 6/3/2025

    Regeneron’s Andres Sirulnik, MD, Ph.D., discusses the importance of seeking "scientific truth" and an unwavering commitment to patient centricity in the context of the company’s hematology research.